Literature DB >> 16772347

Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome.

Antoine Lampron1, Isabelle Bourdeau, Pavel Hamet, Johanne Tremblay, André Lacroix.   

Abstract

CONTEXT: The mechanisms responsible for the ectopic adrenal expression of glucose-dependent insulinotropic peptide (GIP) receptor (GIPR) in GIP-dependent Cushing's syndrome (CS) are unknown. Chronic adrenal stimulation by ACTH in Cushing's disease or GIP in GIP-dependent ACTH-independent macronodular adrenal hyperplasia both lead to the induction of genes implicated in adrenal proliferation and steroidogenesis.
OBJECTIVE: The objective of the study was to identify genes differentially expressed specifically in GIP-dependent CS that could be implicated in the ectopic expression of GIPR.
METHODS: We used the Affymetrix U133 plus 2.0 microarray oligochips to compare the whole genome expression profile of adrenal tissues from five cases of GIP-dependent bilateral ACTH-independent macronodular adrenal hyperplasia with CS, one case of GIP-dependent unilateral adenoma with CS, five cases of ACTH-dependent hyperplasias, and a pool of adrenals from 62 normal individuals.
RESULTS: After data normalization and statistical filtering, 723 genes with differential expression were identified, including 461 genes or sequences with a known functional implication, classified in eight dominant functional classes. Specific findings include repression of perilipin, the overexpression of 13 G protein-coupled receptors, and the potential involvement of Rho-GTPases. We also isolated 94 probe sets potentially linked to the formation of GIP-dependent nodules adjacent to the diffuse hyperplasia. These included probe sets related to the linker histone H1 and repression of RXRa and CCND2. The expression profiles for eight genes were confirmed by real-time RT-PCR.
CONCLUSION: This study identified an extensive series of potentially novel target candidate genes that could be implicated in the molecular mechanisms of ectopic expression of the GIPR as well as in the multistep progression of GIP-dependent CS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772347     DOI: 10.1210/jc.2006-0221

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  How the new tools to analyze the human genome are opening new perspectives: the use of gene expression in investigations of the adrenal cortex.

Authors:  C A Stratakis; A Horvath
Journal:  Ann Endocrinol (Paris)       Date:  2008-04-18       Impact factor: 2.478

Review 2.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

3.  Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.

Authors:  Hu Peng; Yue Deng; Longhao Wang; Yin Cheng; Yaping Xu; Jianchun Liao; Hao Wu
Journal:  J Mol Neurosci       Date:  2019-07-06       Impact factor: 3.444

4.  Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Authors:  Anne-Lise Lecoq; Constantine A Stratakis; Say Viengchareun; Ronan Chaligné; Lucie Tosca; Vianney Deméocq; Mirella Hage; Annabel Berthon; Fabio R Faucz; Patrick Hanna; Hadrien-Gaël Boyer; Nicolas Servant; Sylvie Salenave; Gérard Tachdjian; Clovis Adam; Vanessa Benhamo; Eric Clauser; Anne Guiochon-Mantel; Jacques Young; Marc Lombès; Isabelle Bourdeau; Dominique Maiter; Antoine Tabarin; Jérôme Bertherat; Hervé Lefebvre; Wouter de Herder; Estelle Louiset; André Lacroix; Philippe Chanson; Jérôme Bouligand; Peter Kamenický
Journal:  JCI Insight       Date:  2017-09-21

Review 5.  Genetic Alterations in Benign Adrenal Tumors.

Authors:  Georgia Pitsava; Constantine A Stratakis
Journal:  Biomedicines       Date:  2022-04-30

6.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

7.  Exploration of cardiometabolic and developmental significance of angiotensinogen expression by cells expressing the leptin receptor or agouti-related peptide.

Authors:  Sarah A Sapouckey; Lisa L Morselli; Guorui Deng; Chetan N Patil; Kirthikaa Balapattabi; Vanessa Oliveira; Kristin E Claflin; Javier Gomez; Nicole A Pearson; Matthew J Potthoff; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-03-18       Impact factor: 3.619

Review 8.  Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism.

Authors:  Hervé Lefebvre; Céline Duparc; Gaëtan Prévost; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-20       Impact factor: 5.555

Review 9.  Disorders of the adrenal cortex: Genetic and molecular aspects.

Authors:  Georgia Pitsava; Andrea G Maria; Fabio R Faucz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.